Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s - report from CHEST 2025 episode artwork

EPISODE · Nov 27, 2025 · 13 MIN

Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s - report from CHEST 2025

from Medical Digest & Congress Report · host Medical Congress News

Dr. Cosmo Fowler explains thet data revealed one-year mortality in patients with type 2 diabetes prescribed GLP-1 RAs was substantially lower than those not prescribed the drugs, and disproportionate benefit for those also diagnosed with OSA. The results were presented at the American College of Chest Physicians (CHEST) 2025 Annual Meeting.Video: https://medicaldigest.org/scientific-contents/interview:sleep-apnea-significantly-impacts-mortality-benefit-glp-1s

Episode metadata supplied by the publisher feed · Published Nov 27, 2025

Embed this episode

NOW PLAYING

Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s - report from CHEST 2025

0:00 13:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 13 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on November 27, 2025.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!